腎臓がんがんにおけるピレキシア

A comparative study of methyldopa and labetalol in the treatment of hypertension.

British journal of clinical pharmacology·2015

A multicentre open trial of labetalol in New Zealand.

British journal of clinical pharmacology·2015

Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.

British journal of clinical pharmacology·2015

Mean steady-state plasma concentrations of labetalol in patients undergoing antihypertensive therapy.

British journal of clinical pharmacology·2015

Risk factors for the development of Clostridium difficile toxin-associated diarrhoea: a pilot study.

Pharmacoepidemiology and drug safety·2002

Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions.

Journal of hepatology·2000

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Erratum: Defining the optimal imaging time point for fluorescence-lifetime-based tumor identification using the non-targeting near-infrared dye indocyanine green and post-processed high-dynamic-range images: errata.

Biomedical optics express·2026

Low-Dose Radiotherapy for Benign Achillodynia: A Single Center Experience With Prospective Follow-Up.

Cureus·2026

Microfluidic Isolation of Aptamers for Intracellular Measurement of Radio-Responsive Proteins.

Radiation (Multidisciplinary Digital Publishing Institute)·2026

Microenvironmental remodeling in FLASH radiotherapy.

Frontiers in cell and developmental biology·2026

Open Boari Flap Ureteroneocystostomy in a Radiated Pelvis: A Durable Solution for Complex Distal Ureteric Strictures.

Annals of African medicine·2026

Definitive carbon ion radiotherapy for thoracic bone and soft tissue sarcoma.

BMC cancer·2026

関連する実験動画

腎臓がんがんにおけるピレキシア

関連する概念動画

A comparative study of methyldopa and labetalol in the treatment of hypertension.

A multicentre open trial of labetalol in New Zealand.

Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.

Mean steady-state plasma concentrations of labetalol in patients undergoing antihypertensive therapy.

Risk factors for the development of Clostridium difficile toxin-associated diarrhoea: a pilot study.

Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Erratum: Defining the optimal imaging time point for fluorescence-lifetime-based tumor identification using the non-targeting near-infrared dye indocyanine green and post-processed high-dynamic-range images: errata.

Low-Dose Radiotherapy for Benign Achillodynia: A Single Center Experience With Prospective Follow-Up.

Microfluidic Isolation of Aptamers for Intracellular Measurement of Radio-Responsive Proteins.

Microenvironmental remodeling in FLASH radiotherapy.

Open Boari Flap Ureteroneocystostomy in a Radiated Pelvis: A Durable Solution for Complex Distal Ureteric Strictures.

Definitive carbon ion radiotherapy for thoracic bone and soft tissue sarcoma.

関連する実験動画

腎臓がんがんにおけるピレキシア

関連する概念動画

関連記事